Zelluna Management

Management criteria checks 3/4

Zelluna's CEO is Hans Eid, appointed in Nov 2015, has a tenure of 9.33 years. total yearly compensation is NOK4.41M, comprised of 62.8% salary and 37.2% bonuses, including company stock and options. directly owns 0.17% of the company’s shares, worth NOK123.27K. The average tenure of the management team and the board of directors is 7.6 years and 10.2 years respectively.

Key information

Hans Eid

Chief executive officer

NOK 4.4m

Total compensation

CEO salary percentage62.8%
CEO tenure9.3yrs
CEO ownership0.2%
Management average tenure7.6yrs
Board average tenure10.2yrs

Recent management updates

Recent updates

Companies Like Ultimovacs (OB:ULTI) Can Afford To Invest In Growth

Feb 21
Companies Like Ultimovacs (OB:ULTI) Can Afford To Invest In Growth

Ultimovacs (OB:ULTI) Is In A Strong Position To Grow Its Business

Oct 26
Ultimovacs (OB:ULTI) Is In A Strong Position To Grow Its Business

Companies Like Ultimovacs (OB:ULTI) Are In A Position To Invest In Growth

Oct 05
Companies Like Ultimovacs (OB:ULTI) Are In A Position To Invest In Growth

Ultimovacs (OB:ULTI) Is In A Good Position To Deliver On Growth Plans

May 19
Ultimovacs (OB:ULTI) Is In A Good Position To Deliver On Growth Plans

CEO Compensation Analysis

How has Hans Eid's remuneration changed compared to Zelluna's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024n/an/a

-NOK 201m

Sep 30 2024n/an/a

-NOK 149m

Jun 30 2024n/an/a

-NOK 179m

Mar 31 2024n/an/a

-NOK 178m

Dec 31 2023NOK 4mNOK 3m

-NOK 189m

Sep 30 2023n/an/a

-NOK 204m

Jun 30 2023n/an/a

-NOK 186m

Mar 31 2023n/an/a

-NOK 165m

Dec 31 2022NOK 5mNOK 3m

-NOK 168m

Sep 30 2022n/an/a

-NOK 148m

Jun 30 2022n/an/a

-NOK 153m

Mar 31 2022n/an/a

-NOK 168m

Dec 31 2021n/an/a

-NOK 165m

Sep 30 2021n/an/a

-NOK 138m

Jun 30 2021n/an/a

-NOK 126m

Mar 31 2021n/an/a

-NOK 124m

Dec 31 2020NOK 3mNOK 2m

-NOK 121m

Sep 30 2020n/an/a

-NOK 121m

Jun 30 2020n/an/a

-NOK 108m

Mar 31 2020n/an/a

-NOK 77m

Dec 31 2019NOK 3mNOK 2m

-NOK 61m

Sep 30 2019n/an/a

-NOK 48m

Jun 30 2019n/an/a

-NOK 48m

Mar 31 2019n/an/a

-NOK 59m

Dec 31 2018NOK 2mNOK 2m

-NOK 55m

Compensation vs Market: Hans's total compensation ($USD406.21K) is above average for companies of similar size in the Norwegian market ($USD299.71K).

Compensation vs Earnings: Hans's compensation has been consistent with company performance over the past year.


CEO

Hans Eid

9.3yrs

Tenure

NOK 4,405,000

Compensation

Mr. Hans Vassgard Eid serves as Chief Financial Officer of Zelluna ASA (formerly known as Ultimovacs ASA) since November 2015 and serves as its Interim CEO since 2025. Mr Eid has extensive management exper...


Leadership Team

NamePositionTenureCompensationOwnership
Hans Eid
Interim CEO & CFO9.3yrsNOK 4.41m0.17%
NOK 123.3k
Audun Tornes
Chief Technology Officer4.1yrsNOK 2.92mno data
Jens Egil Bjorheim
Chief Medical Officer8.8yrsNOK 4.29mno data
Oivind Foss
Head of Clinical Operations7.6yrsNOK 2.71mno data
Orla Mc Callion
Head of Regulatory Affairs & QA3.4yrsNOK 2.37mno data
Torill Trones
Head of Officeno datano datano data

7.6yrs

Average Tenure

Experienced Management: ZLNA's management team is seasoned and experienced (7.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jonas Einarsson
Independent Chairman14.2yrsNOK 450.00k0.015%
NOK 11.4k
Kari Gronas
Independent Director6.2yrsNOK 250.00k0.019%
NOK 14.3k
Henrik Schussler
Director10.2yrsNOK 250.00kno data

10.2yrs

Average Tenure

61yo

Average Age

Experienced Board: ZLNA's board of directors are seasoned and experienced ( 10.2 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/10 04:29
End of Day Share Price 2025/03/07 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zelluna ASA is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Geir HolomDNB Markets